Design Therapeutics (DSGN) Q3 2025 Earnings

7AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-0.34
-0.3
-0.27
-0.23

Details

Expected EPS
-0.33
Actual EPS
-0.34
Surprise EPS
-0.01
Surprise Percent
+3.03%

Description

Design Therapeutics (DSGN) has reported earnings of -0.34 per share for Q3 2025.

0 Comments

Share your thoughts